Araştırma Makalesi
PDF EndNote BibTex RIS Kaynak Göster

Bilateral central retinal vein occlusion in non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection

Yıl 2012, Cilt 29, Sayı 1, 80 - 82, 17.04.2012
https://doi.org/10.5835/jecm.omu.29.01.021

Öz

The purpose of this study is to report bilateral central retinal vein occlusion in a patient with non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection. This is a case report of a patient seen and treated in the ophthalmology department of Ondokuz Mayıs University Medical Faculty. Bilateral central retinal vein occlusion was observed in the patient because of hyperviscosity due to non-Hodgkin lymphoma which resulted in decreased visual acuity and increased macular thickness. Bilateral intravitreal bevacizumab injection increased best corrected visual acuity increased and reduced intraretinal, subretinal edema markedly. A hyperviscosity syndrome or inflammatory condition should be suspected when a patient, less than 50 years, has bilateral and simultaneous central retinal vein occlusion. Intravitreal bevacizumab injection is as an effective treatment for intraretinal and subretinal edema in central retinal vein occlusion secondary to non-Hodgkin lymphoma.

Kaynakça

  • Cheung, C.M., Tsaloumas, M.D., 2002. Acute myeloid leukaemia presenting as retinal vein occlusion and eyelid swelling. Eye.16, 202-203.
  • Friedman, A.H., Marchesky, A., Odel, J.G., Gerber, M.A., Thung, S.N., 1980. Immunofluorescent studies of the eye in Waldenstrom's Macro- globulinemia. Arch. Ophthalmol. 98, 743-746.
  • Grindle, C.F., Buskard, N.A., Newman, D.L., 1976. Hyperviscosity retinopathy, a scientific approach to therapy. Trans. Ophthal. Soc. 96, 216- 219.
  • Hayreh, S.S., Zimmerman, M.B., Podhajsky, P., 2002. Hematologic abnormalities associated with various types of retinal vein occlusion. Graef- es Arch. Clin. Exp. Ophthalmol. 240, 180-196.
  • Hayreh, S.S., 2003. Management of central retinal vein occlusion. Ophthalmologica. 217, 167-188.
  • Iturralde, D., Spaide, R.F., Meyerle, C.B., Klancnik, J.M., Yannuzzi, L.A., Fisher, Y.L., Sorenson, J., Slakter, J.S., Freund, K.B., Cooney, M., Fine, H.F., 2006. Intravitreal bevasizumab treatment of macular edema in central retinal vein occlusion: A shorter-term study. Retina. 26, 279-284.
  • Jaissle, G.B., Ziemssen, F., Petermeier, K., Szurman, P., Ladewig, M., Gelisken, F., Völker, M., Holz, F.G., Bartz-Schmidt, K.U., 2006. Bevaci- zumab for treatment of macular edema secondary to retinal vein occlusion. Ophthalmol. 103, 471-475.
  • Kahook, M.Y., Schuman, J.S., Noecker, R.J., 2006. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthal. Surg. Las. Im. 37, 144-146.
  • Priglinger, S.G., Wolf, A.H., Kreutzer, T.C., Kook, D., Hofer, A., Strauss, R.W., Alge, C.S., Kunze, C., Haritoglou, C., Kampik, A., 2007. Intra- vitreal bevacizumab injections for treatment of central retinal vein occlusion. Retina. 27, 1004-1012.
  • Rosenfeld, P.J., Fung, A.E., Puliafito, C.A., 2005. Optical coherence tomography findings after an intravitreal injection of bevacizumab for macular edema from central retinal vein occlusion. Ophthal. Surg. Las. Im. 36, 336-339.
  • Spalter, H.F., 1959. Abnormal serum proteins and retinal vein thrombosis. Arch. Ophthalmol. 52, 868-881.
  • The Central Vein Occlusion Study Group, 1997. Natural history and clinical management of central retinal vein occlusion. Arch. Ophthalmol. 115, 486-491.
  • Williamson, T.H., 1997. Central retinal vein occlusion: What’s the story? Br. J. Ophthalmol. 81, 698-704.

Yıl 2012, Cilt 29, Sayı 1, 80 - 82, 17.04.2012
https://doi.org/10.5835/jecm.omu.29.01.021

Öz

Kaynakça

  • Cheung, C.M., Tsaloumas, M.D., 2002. Acute myeloid leukaemia presenting as retinal vein occlusion and eyelid swelling. Eye.16, 202-203.
  • Friedman, A.H., Marchesky, A., Odel, J.G., Gerber, M.A., Thung, S.N., 1980. Immunofluorescent studies of the eye in Waldenstrom's Macro- globulinemia. Arch. Ophthalmol. 98, 743-746.
  • Grindle, C.F., Buskard, N.A., Newman, D.L., 1976. Hyperviscosity retinopathy, a scientific approach to therapy. Trans. Ophthal. Soc. 96, 216- 219.
  • Hayreh, S.S., Zimmerman, M.B., Podhajsky, P., 2002. Hematologic abnormalities associated with various types of retinal vein occlusion. Graef- es Arch. Clin. Exp. Ophthalmol. 240, 180-196.
  • Hayreh, S.S., 2003. Management of central retinal vein occlusion. Ophthalmologica. 217, 167-188.
  • Iturralde, D., Spaide, R.F., Meyerle, C.B., Klancnik, J.M., Yannuzzi, L.A., Fisher, Y.L., Sorenson, J., Slakter, J.S., Freund, K.B., Cooney, M., Fine, H.F., 2006. Intravitreal bevasizumab treatment of macular edema in central retinal vein occlusion: A shorter-term study. Retina. 26, 279-284.
  • Jaissle, G.B., Ziemssen, F., Petermeier, K., Szurman, P., Ladewig, M., Gelisken, F., Völker, M., Holz, F.G., Bartz-Schmidt, K.U., 2006. Bevaci- zumab for treatment of macular edema secondary to retinal vein occlusion. Ophthalmol. 103, 471-475.
  • Kahook, M.Y., Schuman, J.S., Noecker, R.J., 2006. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthal. Surg. Las. Im. 37, 144-146.
  • Priglinger, S.G., Wolf, A.H., Kreutzer, T.C., Kook, D., Hofer, A., Strauss, R.W., Alge, C.S., Kunze, C., Haritoglou, C., Kampik, A., 2007. Intra- vitreal bevacizumab injections for treatment of central retinal vein occlusion. Retina. 27, 1004-1012.
  • Rosenfeld, P.J., Fung, A.E., Puliafito, C.A., 2005. Optical coherence tomography findings after an intravitreal injection of bevacizumab for macular edema from central retinal vein occlusion. Ophthal. Surg. Las. Im. 36, 336-339.
  • Spalter, H.F., 1959. Abnormal serum proteins and retinal vein thrombosis. Arch. Ophthalmol. 52, 868-881.
  • The Central Vein Occlusion Study Group, 1997. Natural history and clinical management of central retinal vein occlusion. Arch. Ophthalmol. 115, 486-491.
  • Williamson, T.H., 1997. Central retinal vein occlusion: What’s the story? Br. J. Ophthalmol. 81, 698-704.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Bilimleri ve Hizmetleri
Bölüm Surgery Medical Sciences
Yazarlar

Ebru CÖMERT>


Yuksel SULLU>

Yayımlanma Tarihi 17 Nisan 2012
Başvuru Tarihi 16 Ocak 2012
Kabul Tarihi
Yayınlandığı Sayı Yıl 2012, Cilt 29, Sayı 1

Kaynak Göster

Bibtex @araştırma makalesi { omujecm217163, journal = {Journal of Experimental and Clinical Medicine}, issn = {1309-4483}, eissn = {1309-5129}, address = {}, publisher = {Ondokuz Mayıs Üniversitesi}, year = {2012}, volume = {29}, number = {1}, pages = {80 - 82}, doi = {10.5835/jecm.omu.29.01.021}, title = {Bilateral central retinal vein occlusion in non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection}, key = {cite}, author = {Cömert, Ebru and Sullu, Yuksel} }
APA Cömert, E. & Sullu, Y. (2012). Bilateral central retinal vein occlusion in non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection . Journal of Experimental and Clinical Medicine , 29 (1) , 80-82 . DOI: 10.5835/jecm.omu.29.01.021
MLA Cömert, E. , Sullu, Y. "Bilateral central retinal vein occlusion in non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection" . Journal of Experimental and Clinical Medicine 29 (2012 ): 80-82 <https://dergipark.org.tr/tr/pub/omujecm/issue/20425/217163>
Chicago Cömert, E. , Sullu, Y. "Bilateral central retinal vein occlusion in non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection". Journal of Experimental and Clinical Medicine 29 (2012 ): 80-82
RIS TY - JOUR T1 - Bilateral central retinal vein occlusion in non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection AU - EbruCömert, YukselSullu Y1 - 2012 PY - 2012 N1 - doi: 10.5835/jecm.omu.29.01.021 DO - 10.5835/jecm.omu.29.01.021 T2 - Journal of Experimental and Clinical Medicine JF - Journal JO - JOR SP - 80 EP - 82 VL - 29 IS - 1 SN - 1309-4483-1309-5129 M3 - doi: 10.5835/jecm.omu.29.01.021 UR - https://doi.org/10.5835/jecm.omu.29.01.021 Y2 - 2022 ER -
EndNote %0 Journal of Experimental and Clinical Medicine Bilateral central retinal vein occlusion in non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection %A Ebru Cömert , Yuksel Sullu %T Bilateral central retinal vein occlusion in non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection %D 2012 %J Journal of Experimental and Clinical Medicine %P 1309-4483-1309-5129 %V 29 %N 1 %R doi: 10.5835/jecm.omu.29.01.021 %U 10.5835/jecm.omu.29.01.021
ISNAD Cömert, Ebru , Sullu, Yuksel . "Bilateral central retinal vein occlusion in non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection". Journal of Experimental and Clinical Medicine 29 / 1 (Nisan 2012): 80-82 . https://doi.org/10.5835/jecm.omu.29.01.021
AMA Cömert E. , Sullu Y. Bilateral central retinal vein occlusion in non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection. J. Exp. Clin. Med.. 2012; 29(1): 80-82.
Vancouver Cömert E. , Sullu Y. Bilateral central retinal vein occlusion in non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection. Journal of Experimental and Clinical Medicine. 2012; 29(1): 80-82.
IEEE E. Cömert ve Y. Sullu , "Bilateral central retinal vein occlusion in non-Hodgkin lymphoma and the effects of intravitreal bevacizumab injection", Journal of Experimental and Clinical Medicine, c. 29, sayı. 1, ss. 80-82, Nis. 2012, doi:10.5835/jecm.omu.29.01.021